Urinary cell mRNA profiles predictive of human kidney allograft status

John R. Lee, Thangamani Muthukumar, Darshana Dadhania, Ruchuang Ding, Vijay K. Sharma, Joseph E. Schwartz, Manikkam Suthanthiran

Research output: Contribution to journalReview article

23 Citations (Scopus)

Abstract

Kidney allograft status is currently characterized using the invasive percutaneous needle core biopsy procedure. The procedure has become safer over the years, but challenges and complications still exist including sampling error, interobserver variability, bleeding, arteriovenous fistula, graft loss, and even death. Because the most common type of acute rejection is distinguished by inflammatory cells exiting the intravascular compartment and gaining access to the renal tubular space, we reasoned that a kidney allograft may function as an in vivo flow cytometer and sort cells involved in rejection into urine. To test this idea, we developed quantitative polymerase chain reaction (PCR) assays for absolute quantification of mRNA and pre-amplification protocols to overcome the low RNA yield from urine. Here, we review our single center urinary cell mRNA profiling studies that led to the multicenter Clinical Trials in Organ Transplantation (CTOT-04) study and the discovery and validation of a 3-gene signature of 18S rRNA-normalized measures of CD3ε mRNA and IP-10 mRNA and 18S rRNA that is diagnostic and predictive of acute cellular rejection in the kidney allograft. We also review our development of a 4-gene signature of mRNAs for vimentin, NKCC2, E-cadherin, and 18S rRNA diagnostic of interstitial fibrosis/tubular atrophy (IF/TA).

Original languageEnglish
Pages (from-to)218-240
Number of pages23
JournalImmunological Reviews
Volume258
Issue number1
DOIs
Publication statusPublished - 1 Jan 2014
Externally publishedYes

Fingerprint

Allografts
Kidney
Messenger RNA
Urine
Large-Core Needle Biopsy
Observer Variation
Selection Bias
Validation Studies
Arteriovenous Fistula
Organ Transplantation
Vimentin
Cadherins
Genes
Multicenter Studies
Atrophy
Fibrosis
Clinical Trials
RNA
Hemorrhage
Transplants

Keywords

  • Acute cellular rejection
  • Interstitial fibrosis
  • Kidney transplantation
  • PCR
  • Urinary cell mRNA profiling

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Lee, J. R., Muthukumar, T., Dadhania, D., Ding, R., Sharma, V. K., Schwartz, J. E., & Suthanthiran, M. (2014). Urinary cell mRNA profiles predictive of human kidney allograft status. Immunological Reviews, 258(1), 218-240. https://doi.org/10.1111/imr.12159

Urinary cell mRNA profiles predictive of human kidney allograft status. / Lee, John R.; Muthukumar, Thangamani; Dadhania, Darshana; Ding, Ruchuang; Sharma, Vijay K.; Schwartz, Joseph E.; Suthanthiran, Manikkam.

In: Immunological Reviews, Vol. 258, No. 1, 01.01.2014, p. 218-240.

Research output: Contribution to journalReview article

Lee, JR, Muthukumar, T, Dadhania, D, Ding, R, Sharma, VK, Schwartz, JE & Suthanthiran, M 2014, 'Urinary cell mRNA profiles predictive of human kidney allograft status', Immunological Reviews, vol. 258, no. 1, pp. 218-240. https://doi.org/10.1111/imr.12159
Lee JR, Muthukumar T, Dadhania D, Ding R, Sharma VK, Schwartz JE et al. Urinary cell mRNA profiles predictive of human kidney allograft status. Immunological Reviews. 2014 Jan 1;258(1):218-240. https://doi.org/10.1111/imr.12159
Lee, John R. ; Muthukumar, Thangamani ; Dadhania, Darshana ; Ding, Ruchuang ; Sharma, Vijay K. ; Schwartz, Joseph E. ; Suthanthiran, Manikkam. / Urinary cell mRNA profiles predictive of human kidney allograft status. In: Immunological Reviews. 2014 ; Vol. 258, No. 1. pp. 218-240.
@article{d4f5afa8cccf42678a2d9510e8f2c16c,
title = "Urinary cell mRNA profiles predictive of human kidney allograft status",
abstract = "Kidney allograft status is currently characterized using the invasive percutaneous needle core biopsy procedure. The procedure has become safer over the years, but challenges and complications still exist including sampling error, interobserver variability, bleeding, arteriovenous fistula, graft loss, and even death. Because the most common type of acute rejection is distinguished by inflammatory cells exiting the intravascular compartment and gaining access to the renal tubular space, we reasoned that a kidney allograft may function as an in vivo flow cytometer and sort cells involved in rejection into urine. To test this idea, we developed quantitative polymerase chain reaction (PCR) assays for absolute quantification of mRNA and pre-amplification protocols to overcome the low RNA yield from urine. Here, we review our single center urinary cell mRNA profiling studies that led to the multicenter Clinical Trials in Organ Transplantation (CTOT-04) study and the discovery and validation of a 3-gene signature of 18S rRNA-normalized measures of CD3ε mRNA and IP-10 mRNA and 18S rRNA that is diagnostic and predictive of acute cellular rejection in the kidney allograft. We also review our development of a 4-gene signature of mRNAs for vimentin, NKCC2, E-cadherin, and 18S rRNA diagnostic of interstitial fibrosis/tubular atrophy (IF/TA).",
keywords = "Acute cellular rejection, Interstitial fibrosis, Kidney transplantation, PCR, Urinary cell mRNA profiling",
author = "Lee, {John R.} and Thangamani Muthukumar and Darshana Dadhania and Ruchuang Ding and Sharma, {Vijay K.} and Schwartz, {Joseph E.} and Manikkam Suthanthiran",
year = "2014",
month = "1",
day = "1",
doi = "10.1111/imr.12159",
language = "English",
volume = "258",
pages = "218--240",
journal = "Immunological Reviews",
issn = "0105-2896",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Urinary cell mRNA profiles predictive of human kidney allograft status

AU - Lee, John R.

AU - Muthukumar, Thangamani

AU - Dadhania, Darshana

AU - Ding, Ruchuang

AU - Sharma, Vijay K.

AU - Schwartz, Joseph E.

AU - Suthanthiran, Manikkam

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Kidney allograft status is currently characterized using the invasive percutaneous needle core biopsy procedure. The procedure has become safer over the years, but challenges and complications still exist including sampling error, interobserver variability, bleeding, arteriovenous fistula, graft loss, and even death. Because the most common type of acute rejection is distinguished by inflammatory cells exiting the intravascular compartment and gaining access to the renal tubular space, we reasoned that a kidney allograft may function as an in vivo flow cytometer and sort cells involved in rejection into urine. To test this idea, we developed quantitative polymerase chain reaction (PCR) assays for absolute quantification of mRNA and pre-amplification protocols to overcome the low RNA yield from urine. Here, we review our single center urinary cell mRNA profiling studies that led to the multicenter Clinical Trials in Organ Transplantation (CTOT-04) study and the discovery and validation of a 3-gene signature of 18S rRNA-normalized measures of CD3ε mRNA and IP-10 mRNA and 18S rRNA that is diagnostic and predictive of acute cellular rejection in the kidney allograft. We also review our development of a 4-gene signature of mRNAs for vimentin, NKCC2, E-cadherin, and 18S rRNA diagnostic of interstitial fibrosis/tubular atrophy (IF/TA).

AB - Kidney allograft status is currently characterized using the invasive percutaneous needle core biopsy procedure. The procedure has become safer over the years, but challenges and complications still exist including sampling error, interobserver variability, bleeding, arteriovenous fistula, graft loss, and even death. Because the most common type of acute rejection is distinguished by inflammatory cells exiting the intravascular compartment and gaining access to the renal tubular space, we reasoned that a kidney allograft may function as an in vivo flow cytometer and sort cells involved in rejection into urine. To test this idea, we developed quantitative polymerase chain reaction (PCR) assays for absolute quantification of mRNA and pre-amplification protocols to overcome the low RNA yield from urine. Here, we review our single center urinary cell mRNA profiling studies that led to the multicenter Clinical Trials in Organ Transplantation (CTOT-04) study and the discovery and validation of a 3-gene signature of 18S rRNA-normalized measures of CD3ε mRNA and IP-10 mRNA and 18S rRNA that is diagnostic and predictive of acute cellular rejection in the kidney allograft. We also review our development of a 4-gene signature of mRNAs for vimentin, NKCC2, E-cadherin, and 18S rRNA diagnostic of interstitial fibrosis/tubular atrophy (IF/TA).

KW - Acute cellular rejection

KW - Interstitial fibrosis

KW - Kidney transplantation

KW - PCR

KW - Urinary cell mRNA profiling

UR - http://www.scopus.com/inward/record.url?scp=84893583540&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84893583540&partnerID=8YFLogxK

U2 - 10.1111/imr.12159

DO - 10.1111/imr.12159

M3 - Review article

C2 - 24517436

AN - SCOPUS:84893583540

VL - 258

SP - 218

EP - 240

JO - Immunological Reviews

JF - Immunological Reviews

SN - 0105-2896

IS - 1

ER -